Epidemiological trends of hepatitis viral infections: a retrospective study utilizing serological data from a tertiary laboratory in jordan

HIGHLIGHTS

• What: By focusing on sero-prevalence, this study seeks to present a clearer picture of HAV, HBV, and HCV exposure rates in Jordan. The study`s HBsAg findings, showing a relatively low sero-prevalence of 3.9%-6.8% over six years, align with previous reports estimating national HBV prevalence in Jordan at around 2.4%.5 This study reported a sero-prevalence of HBsAg of 4.4% in 2017, 3.9% in 2018, 5.8% in 2019, 4.8% in 2020, 6.8% in 2021, and 2.8% in 2022, reflecting a decline from 9.9 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.